Search Results - "Ramos Tejo Salgado, Marcelo"
-
1
Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer
Published in Journal of surgical oncology (01-09-2024)“…Background Locally advanced triple‐negative breast cancer (TNBC) represents a public health problem in Brazil. Its standard treatment consists of neoadjuvant…”
Get full text
Journal Article -
2
Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor–positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study
Published in Journal of clinical oncology (01-06-2022)“…589 Background: Endocrine therapy (ET) is the therapeutic mainstay for ER+ BC. Giredestrant is a highly potent, nonsteroidal, oral, selective ER antagonist and…”
Get full text
Journal Article -
3
Embryonal Rhabdomyosarcoma of the Maxilla: a Case Report
Published in Oral surgery, oral medicine, oral pathology and oral radiology (01-09-2018)Get full text
Journal Article